TATAA Biocenter Receives French Ministry Approval
News Aug 12, 2014
TATAA Biocenter, Europe´s leading provider of genomic services, has been approved by the French Ministry of Higher Education and Research (www.recherche.gouv.fr) as an organization carrying out R&D activities for the account of private companies. “This entitles our French customers tax reduction” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter, “and makes us even more competitive on the French market, where we already have the pleasure of serving some of Europe´s most innovative Life Science companies”
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019